NHS
Get informed when a big investor buys or sells
+ FollowOvervalued by 45.8% based on the discounted cash flow analysis.
| Market cap | $192.08 Million |
|---|---|
| Enterprise Value | $326.07 Million |
| Dividend Yield | $1.09 (17.75%) |
| Earnings per Share | $0.66 |
| Beta | 0.76 |
| Outstanding Shares | 30,746,750 |
| P/E Ratio | 9.27 |
|---|---|
| PEG | 42.93 |
| Price to Sales | 6.21 |
| Price to Book Ratio | 0.69 |
| Enterprise Value to Revenue | 6.61 |
| Enterprise Value to EBIT | 7.79 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.41 |
| Debt to Equity | 0.47 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 21.89%▲ 8.83% |
|---|---|
| Total Invested | $43.46M▲ 45.45% |
| Investors Holding | 54▲ 11.00% |
No data
Neuberger Berman High Yield Strategies Fund Inc. is a diversified, closed-end management investment company investing in the high yield debt securities market. The Fund utilizes leverage through the issuance of privately placed notes and preferred stock.